The agenda features an Exchange Strategy Summit, case studies and expert panels led by a diverse group of industry experts representing Acorda Therapeutics, Astellas, AstraZeneca, Apexus, Auxilium, BIO, Durata Therapeutics, Grifols, Lilly, Orexo and West-Ward, all set to deliver solutions to the most significant challenges affecting industry today:
- Reimbursement trends and the impact on market access
- Contracting and compliance challenges with the implementation of the ACA
- The underlying terrain of the exchange marketplace, open enrollment and implications for pharma
- Insight into various gold, silver and bronze metal plans
- Strategies to engage with ACOs and ensure product access
- 340B intricacies and programs updates
- The impact of Medicaid expansion on pricing, contracting and reimbursement, patient assistance programs and co-pay offset strategies
- And much, much more!
* Offer valid through February 7, 2014, applies to standard rates only and may not be combined with other offers, category rates, promotions or applied to a current registration.